- Record: found
- Abstract: not found
- Article: not found
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B El-Khoueiry ,
Bruno Sangro ,
Thomas Yau ,
Todd S Crocenzi ,
Masatoshi Kudo ,
Chiun Hsu ,
Tae-You Kim ,
Su-Pin Choo ,
Jörg Trojan ,
Theodore H Welling ,
Tim Meyer ,
Yoon-Koo Kang ,
Winnie Yeo ,
Akhil Chopra ,
Jeffrey Anderson ,
Christine dela Cruz ,
Lixin Lang ,
Jaclyn Neely ,
Hao Tang ,
Homa B Dastani ,
Ignacio Melero
June 2017
June 2017
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.